Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1700 in its research report dated August 06, 2025.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1975 in its research report dated August 06, 2025.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1740 in its research report dated May 20, 2025.
Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1350 in its research report dated May 19, 2025.
Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1270 in its research report dated February 04, 2025.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1450 in its research report dated February 05, 2025.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1420 in its research report dated October 26, 2024.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1250 in its research report dated August 05, 2024.
Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 930 in its research report dated March 14, 2024.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 23, 2024.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1050 in its research report dated November 09, 2023.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 910 in its research report dated August 08, 2023.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 780 in its research report dated May 18, 2023.
Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 720 in its research report dated May 17, 2023.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 780 in its research report dated March 17, 2023.
Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 780 in its research report dated January 18, 2023.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated January 18, 2023.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated October 25, 2022.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 825 in its research report dated August 08, 2022.
Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated May 16, 2022.
Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated May 05, 2022.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated May 05, 2022.
Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated December 27, 2021.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 954 in its research report dated December 06, 2021.
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 666 in its research report dated January 28, 2021.